Hi Guest
Real-Time Quote
Enter Company or MFTransgene Biotek Ltd.
526139 TRABI Group (B) BSE data
Add to Watchlist
| View Tips
How hot is this stock? © Rediff.com
Price*
Volume*
MF holdings
Sales
Net profit margin
Volume*
MF holdings
Sales
Net profit margin
* Computed on last 15 days' trading figures.
Report card
| Attribute | Value | Date |
|---|---|---|
| PE ratio | 706.06 | 23/05/12 |
| EPS (Rs) | 0.04 | Mar, 11 |
| Sales (Rs crore) | 8.54 | Dec, 11 |
| Face Value (Rs) | 10 | |
| Net profit margin (%) | 1.36 | Mar, 11 |
| Return on average equity | 0.07 | Mar, 11 |
Research centre
Results Statement More
AnnouncementsMore 
| 03:19 PM | Transgene reports excellent results from TrabiOral oral insulin studies
 | |
| 27 Apr | Transgene Biotek continues its forey westwards
| |
| 22 Mar | Change in Compliance Officer | |
| 23 Feb | Limited Review for Dec 31, 2011
| |
| 23 Nov 2011 | Sale of Technology by Transgene
| |
| 15 Nov 2011 | Financial Results for Sep 30, 2011
| |
| 07 Sep 2011 | Fixes Book Closure for AGM | |
| 16 Aug 2011 | Financial Results for Jun 30, 2011
| |
| 16 May 2011 | Financial Results for Mar 31, 2011
| |
| 16 May 2011 | Transgene Biotek to commence commercial production of another API - DHA
| |
Compare with
Add Your Stock Call
Thank you. Your call will appear shortly. Your returns will be updated at the end of the trading day. View All CallsMutual Fund Selector
Find the fund that is right for youCreate your Portfolio
Track your investments and get daily updatesAll MoneyWiz Pages
© Copyright 2012 Rediff.com India Limited. All rights reserved. DisclaimerTerms of ServicePrivacy PolicyFeedback